Bristol Myers Squibb Receives US FDA Approval of New State-of-the-Art Cell Therapy Manufacturing Facility in Devens, Massachusetts

Bristol Myers Squibb announced that the US FDA has approved commercial production at the company’s newest cell therapy manufacturing facility in Devens, Massachusetts.